Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

214 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

2706 (92%)

2930

Discontinuation Reports

To be discontinued:

2 (1%)

Discontinued:

298 (99%)

Reversed:

0 (0%)

300

363 (11%)

101 (47%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-MORPHINE SR 200MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-10-29 160448
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2021-08-27 2021-11-11 144755
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2021-09-09 2021-12-08 145446
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2021-09-16 2021-11-11 145791
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-04 2023-08-04 197169
TEVA-MORPHINE SR 200MG TABLET (EXTENDED-RELEASE) Resolved 2024-11-08 2025-02-13 242364
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-05-08 110712
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-05-08 110716
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-05-09 110719
TEVA-MORPHINE SR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-04-23 110722
TEVA-MORPHINE SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-05-08 110725
TEVA-MORPHINE SR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-18 2020-10-22 118247
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-01 2020-10-30 125467
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-01 2023-02-09 176854
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-22 2023-02-09 179303
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-08 2023-06-27 194125
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-06-21 195210
TEVA-MOXIFLOXACIN 400MG TABLET Actual shortage 2023-06-08 2024-04-11 194157
TEVA-MOXIFLOXACIN 400MG TABLET Resolved 2023-06-20 2023-07-06 195847
TEVA-MOXIFLOXACIN 400MG TABLET Resolved 2017-04-03 2017-10-10 5216
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
METHOTREXATE SODIUM INJECTION 25MG SOLUTION Discontinued 2025-04-25 2025-04-25 255818
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.5G 4G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210194
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626